Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanchun Guo

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|April 19, 2005
Linking transcriptional elongation and messenger RNA export to metastatic breast cancersShanchun Guo, Mohamed-Ali Hakimi, David Baillat, et al.
Journal of Medicinal Chemistry|October 3, 2024
Discovery of Oral Degraders of the ROS1 Fusion Protein with Potent Activity against Secondary Resistance MutationsXianyou Peng, Shanchun Guo, Shilong Zheng, et al.
European Journal of Medicinal Chemistry|June 12, 2017
Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studiesXiaojie Zhang, Shanchun Guo, Chengsheng Chen, et al.
Journal of Medicinal Chemistry|August 17, 2016
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)Jiawang Liu, Shilong Zheng, Victoria L Akerstrom, et al.
Oncotarget|February 23, 2018
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft modelsShanchun Guo, Changde Zhang, Melyssa Bratton, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|April 19, 2005
Linking transcriptional elongation and messenger RNA export to metastatic breast cancersShanchun Guo, Mohamed-Ali Hakimi, David Baillat, et al.
Journal of Medicinal Chemistry|October 3, 2024
Discovery of Oral Degraders of the ROS1 Fusion Protein with Potent Activity against Secondary Resistance MutationsXianyou Peng, Shanchun Guo, Shilong Zheng, et al.
European Journal of Medicinal Chemistry|June 12, 2017
Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studiesXiaojie Zhang, Shanchun Guo, Chengsheng Chen, et al.
Journal of Medicinal Chemistry|August 17, 2016
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)Jiawang Liu, Shilong Zheng, Victoria L Akerstrom, et al.
Oncotarget|February 23, 2018
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft modelsShanchun Guo, Changde Zhang, Melyssa Bratton, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Pageof 7